Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Zealand Pharma A/S Amgen Inc Chugai Pharmaceutical Co Ltd
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Internet Novo Nordisk A/S Hospitals
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Healthy Returns Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags World News Europe Markets Health care industry
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Breaking News: Technology Hims & Hers Health Inc Health & Science
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Carmot Therapeutics Inc Health care industry Companies
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Healthy Returns Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Eli Lilly and Co US: News Science
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Eli Lilly and Co Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Biotechnology Business Health & Science
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Health care industry Companies Amgen Inc
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Amgen Inc Breaking news Companies
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Novo Nordisk A/S Pharmaceuticals Earnings
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Health & Science Business Biotechnology
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Novo Nordisk A/S Congress Biotech and Pharmaceuticals
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Health care industry Breaking news Social issues
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Breaking news Jack in the Box Inc Health care industry
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Breaking news Companies Health care industry
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Eli Lilly and Co US: News Science
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Companies Health care industry Sanofi SA
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Tags Food and Beverage US: News Business
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Biotech and Pharmaceuticals Novo Nordisk A/S AstraZeneca PLC
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
Tags Companies Health care industry Eli Lilly and Co
From CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
Tags Science US: News Health & Science
From CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
Tags Business News Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
Tags Health & Science Business Biotechnology
From CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
Tags Alphabet Inc Markets ETF Edge
From CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
Tags Business News Health care industry Novo Nordisk A/S
From CNBC.com News
Cramer's Lighting Round: Arm is a buy
Tags U/S/ Markets Investment Strategy Raymond James Financial Inc
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.